Related Experiment Videos
The genetics of retinoblastoma
1Laboratoire de Génétique, Faculté de Médecine, Marseille, France.
Abstract:
Retinoblastoma is a malignant tumor of the eye that affects about one in 20,000 young children and occurs as hereditary and non-hereditary (sporadic) forms. It results from successive loss or inactivation of the two alleles of the Rb1 gene, located in 13q14. A chromosomal deletion in 13q14 is revealed by cytogenetic investigation in about 5% of affected patients. Molecular studies have confirmed that inactivation of both alleles of the Rb1 gene, even by point mutation, is required for tumorigenesis, leading to the concept of antioncogenes or tumor suppressor genes. The protein (p110RB) produced by the Rb1 gene is involved in cell cycle regulation. Absence or abnormal forms of the protein may result in deregulation of the cell cycle and subsequent cell proliferation. Association of p110RB with viral oncoproteins may be a step in tumorigenesis. Differences in penetrance and expressivity among families, could be explained by balanced insertional translocation and by defects of the Rb1 gene, which codes for a shortened Rb protein with partial oncosuppressor function. Techniques allowing analysis of Rb1 mutations can be successfully used to predict or exclude the development of retinoblastoma in newborn infants.
Insights
Retinoblastoma, a childhood eye cancer, arises from Rb1 gene inactivation. Analyzing Rb1 gene mutations helps predict and prevent this tumor in infants.
Area of Science:
- Ophthalmology
- Oncology
- Molecular Biology
Background:
- Retinoblastoma is a common malignant eye tumor in young children, occurring in hereditary and sporadic forms.
- It is caused by the inactivation of both alleles of the Rb1 gene, a tumor suppressor gene located at 13q14.
- The Rb1 gene product, p110RB protein, is crucial for regulating the cell cycle.
Purpose of the Study:
- To explore the genetic basis of retinoblastoma, focusing on the Rb1 gene.
- To understand the role of Rb1 gene mutations and p110RB protein in tumorigenesis.
- To evaluate the utility of Rb1 mutation analysis for predicting retinoblastoma development.
Main Methods:
- Cytogenetic investigation to detect chromosomal deletions at 13q14.
- Molecular studies to identify point mutations and inactivation of Rb1 gene alleles.
- Analysis of Rb1 gene mutations for predicting disease risk.
Main Results:
- Inactivation of both Rb1 alleles, through deletion or mutation, is necessary for retinoblastoma development.
- Absence or abnormal p110RB protein leads to cell cycle deregulation and proliferation.
- Rb1 gene analysis can predict or exclude retinoblastoma in newborns.
Conclusions:
- The Rb1 gene and its protein product are critical in preventing retinoblastoma.
- Understanding Rb1 gene defects is key to managing hereditary and sporadic retinoblastoma.
- Rb1 mutation analysis offers a valuable tool for early detection and prevention strategies.